pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3179-1 |
Genomic Coordinates | chr16: 14901508 - 14901591 |
Description | Homo sapiens miR-3179-1 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-2 |
Genomic Coordinates | chr16: 16300159 - 16300242 |
Description | Homo sapiens miR-3179-2 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-3 |
Genomic Coordinates | chr16: 18411894 - 18411977 |
Description | Homo sapiens miR-3179-3 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-4 |
Genomic Coordinates | chr16: 18494493 - 18494576 |
Description | Homo sapiens miR-3179-4 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3179 | |||||||||||||||
Sequence | 52| AGAAGGGGUGAAAUUUAAACGU |73 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NAV2 | ||||||||||||||||||||
Synonyms | HELAD1, POMFIL2, RAINB1, STEERIN2, UNC53H2 | ||||||||||||||||||||
Description | neuron navigator 2 | ||||||||||||||||||||
Transcript | NM_001111018 | ||||||||||||||||||||
Other Transcripts | NM_001111019 , NM_145117 , NM_182964 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NAV2 | |||||||||||||||||||||
3'UTR of NAV2 (miRNA target sites are highlighted) |
>NAV2|NM_001111018|3'UTR 1 CAGGGGCCCGGAGCCCAGCGCCCTCCTCTTCTCCTCACCGCATTCCACCTGCATCCCCCACATCACCCTGAAGATGACTT 81 CCTGAGCCAGCCCCCAGCCACAGCCTTAGAGCTGCGGGAACACCGAGACCCCCCGTCCTTCAGCCTCGACCTGGGTGCAG 161 GCATCCCGGGCCAGCTGCCTGCGGACCGCTTCCTTCCACAGCGAGAACTGCACTACCTTCTGTTGTACTTTAATTATTGT 241 TTTGCCTTGTTGCTGTGACCTCCCTAAGACACTGAAGATACTTCTCGGGAAAGGATCATCGCCGTTGAAATGAAAAGAGA 321 GACAGAGAGAAAAAAAAAAAGAGAACCCACATGAAGCTCTGAAACCAAACAGCATCCTGCCATGAGCTTCCCAGAGACAG 401 AAGAGACTGGAGCAAAGTCGGAAACACAGAGAAGCACGGCTTCCCCTCAGCACAGACCCTCCAGACTGGGTCTCAGAGCC 481 GTGCCACCCACCCTCCCACACAGCCGGCCACAGGGAGAACTGGTGCTAACCAGGGTGCTTGCTTTGGTCACGTTCAACGC 561 ACTACAGAGCTACGACACAGGGAAACCTTAGGAGCAAATAAACCGTGCTTTCATGTTTTTTAAATGGTGCTTTCCTTACC 641 CGAGAGGTATTTTGCCTGTTCCAATCAAACCACCCCATTCAGGTCCATCAGCCTCTGATTAATATCCGTGAGAGTGAGTG 721 ACGGAGTGAGAGTGTGAGCGAGTGGATGTGGCTGTCAGTGCAGAACAGCATGTGTCTCTTTCCTTCTGATATATGAATGA 801 ATCAGGTTTTTTTTTTTTTTTTTCTGCAAACACTGTGTATAGTGAGACTTGTTCTACTTTGGAGAACAGGTTACCTTTTG 881 AAAATGAGGTTGAGTTTCTTCCTTTCTGATGCATTGATTTTTGAAGATTTTTTTTTCCCCCTTCCCCTCTTGGTCAGAAT 961 CAATCCTTTGGTGAAAGTAAGAACCGCAGGAGTTGAGTTTTGGTTTGGTCCTGCTCAGTTTTGGTTTTTAGTTGTCCATC 1041 CTCACAGTCCTACACACTCGCCTCCTCCTGCTAGGGCTGGGGGTATCTGTGTCCTTTAAAATGGATGAGGACCTGGTCCT 1121 CGACATGTGGGTGAGCCATGGACCTTGCCTTCCCTTCTCGTCCTTGAGGGTTTAGAACACACACCAACACCTCCAGCGTC 1201 CCCGCCCCAGCTTCCGGTGGGGTGATGCGGTCACCCTGCAAAAGACTTGCACTTTCCTCAGAACCAACATGACGCAGCTC 1281 AATAAGGGTGAGGGTCACTCCCTCCCAGAAGCCCCGTCTGGACGAGCCTTGCCTGACCTCTTCGGTGCTGACCTTCCCAA 1361 AGTGATGCCTTACTGGTTTTGTACTAACTGTGTTCATTTTACATAAGTGTCGTGCCTGCCTGGGGTTTGTTTTTTTTGTC 1441 ATTGTTTTCCCCATTGAAACAAACAGGGCTAAAAAGTCATCTGTTCATTAGGAGAACTCAAGTTGCTGTGACTTTTCTCA 1521 TCCAAAAGACTCATTTGTGTGGATGCGTGACCATGGGAAAAAGAAAAAAAAAAAGATCCATTTTTTAGGTTCTTTTCGGT 1601 CTCCAGCTGACAACCCAACTGGACAATGATCTGTCTGGTGCAGGAGAAGGCAAAAGTTTCTACAAGTCTACATGACCTTG 1681 CTGATACTTGTTCTAATAGAAACCCAGTCTGCTGTGTCTTCAACATACTGGTATTTTCATTACAAAGTATGGTAAATTTT 1761 TGAGTTGTTTGTTTCTGTTTTGTAAAGAGAATCCTTATTGGACACCAGTGAAGGTGTCTCTGTTTTAATGATCAGGGTTT 1841 TTATTCCATCTTTTGCATTTCTTCTATTTCTGAAGGTTTGTCTCTTGGCATCTTTTTTTAGTTTCTTACCATAAGAGTTT 1921 GACCCGAAACTGCTCACTTCACATTGGATGACACCATGTTCTTCCTCTTTGAAAAGAAAAGGGGAATGTGTCCCACTAGT 2001 GAAAGGAAAACTTTTCAACACTATCCCTGCTTTAGTCTCAGCAAACTCAGACTATTCTGCTTAGCCTTCATTAGTCATCT 2081 GGGTGTGAGTGTGTCTTGTTCTGTTTTTCTTTTTAATAAAACTTTTAAACCATATATTTAGCCTGTGACCAGGGGGGCCA 2161 AACCCTAAGATTTCTGGTAAACCTGAAGGGTGGCCCTCCTCAGACAATTTATCTCCCAGCAATGACCCTACTACACTCGC 2241 GTACTGTGAATTTGGGAGGAGGTAAAGTTGACTTCTCCTCGTGGGCAGTTTTCCAATCACCTTGTGAGTAGACACCTGCC 2321 AATATTGTTTGAAACCTTTTTTTAATATGACATCCTCTCTTGTCATTCTCTTCTCCCCTTTCCCACAGACTTCCCTCCTG 2401 GGTCCAGGTTCAGAACCAAGACTTCTGTACCTAGTGCTGCCTGATTGGTGAACATTGACTTCAAGTAGCATAGCCCTTGT 2481 GTGACTCACAACTCCGTGTCCTTCCTAAAGTTTCGGGAAGCAGGGTTGTCTAATATGCACATTTCTTATTTTGGTCATAT 2561 TTTTACTTTAGTGTCACTCACCTTTTACAAAGTGACTTTGTACTCATTTAGGGCTCTATCGGAAATGCTTCCATTTTGCC 2641 TTTTCTACAGTTAGGCCAATTTTGAAATATATAAATTCTATGCAACATTTATGTTGAGTTACCAATGGAAGCCAAAAGTT 2721 CTCTTCCCAAACTGCCAAGAATGATACAGGCCATAATTGAAATGGGAATACCTTTTAAGTTTCATTAGGGGTGGGGTGGG 2801 AGTGGGACAGGAACAAGACTTGCCTAGATCTTTGTTGTATCTTGGGGACTTTTACTTTGTTGTTTGATGCTTAAACTTCA 2881 AAATTCTCTGTATTCAAATTTGATTGTGGCGAATCTACTTCAAAAAGGAAAAATAATCCAACTTTGTGGATATTAAATGG 2961 AAGGTTTGCTGTTTTGATCTAGTTGTTTCCAGTGGAGCAGTTTTATGAAATATGTTCTATAAGATGTACATTTTTTCATT 3041 GTAACATAGAAATTGTAAATAATTGATTAAAGTGCTGCATTTTGATGAATTTTTTCTAGCCATTTTTAAAGAGAAAACTA 3121 GGAATTGAGTATTTTGTGTACGGTATGTTTCCATCCTCCCTCCCCTTCCTCCTCCCCTCCTCTCTCTCTCTTCCTACCTA 3201 TTTAATTTTCATTTGTCATGAGGTTTTTGGATTTGCCAATGATCTGCTGGACATCATGCCCCATGTCATAGAGAATAAAG 3281 CTGATGATTGTACCAGTCTTAAATTATTCATGATTCAATAAAATTGATGCTTATTTATTCAGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 , TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_145117 | 3UTR | UUUUUGAAGAUUUUUUUUUCCCCCUUCCCCUCUUGGUCAGAAUCAAUCCUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_145117 | 3UTR | CCCCUCUUGGUCAGAAUCAAUCCUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_145117 | 3UTR | UUUGAAGAUUUUUUUUUCCCCCUUCCCCUCUUGGUCAGAAUCAAUCCUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_145117 | 3UTR | UUCCCCUCUUGGUCAGAAUCAAUCCUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_145117 | 3UTR | CCUUCCCCUCUUGGUCAGAAUCAAUCCUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_145117 | 3UTR | UGAUUUUUGAAGAUUUUUUUUUCCCCCUUCCCCUCUUGGUCAGAAUCAAUCCUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000360655.4 | 3UTR | CCUCCUCCCCUCCUCUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000360655.4 | 3UTR | CCUCCUCCCCUCCUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000360655.4 | 3UTR | CCUCCUCCCCUCCUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000360655.4 | 3UTR | CCUCCUCCCCUCCUCUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000360655.4 | 3UTR | CUCCCCUUCCUCCUCCCCUCCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1462573 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000360655.4 | 3UTR | CUCCCCUUCCUCCUCCCCUCCUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 13 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000360655.4 | 3UTR | CCUCCUCCCCUCCUCUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
133 hsa-miR-3179 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT102087 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT110061 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | ![]() |
![]() |
2 | 6 | ||||||
MIRT112198 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT117668 | SCAMP4 | secretory carrier membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT146657 | MINK1 | misshapen like kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT175505 | ZBTB33 | zinc finger and BTB domain containing 33 | ![]() |
![]() |
2 | 4 | ||||||
MIRT180535 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT190624 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT190650 | PABPN1 | poly(A) binding protein nuclear 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT366902 | NONO | non-POU domain containing octamer binding | ![]() |
![]() |
2 | 2 | ||||||
MIRT443554 | ZFP3 | ZFP3 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT445953 | MLLT11 | MLLT11, transcription factor 7 cofactor | ![]() |
![]() |
2 | 2 | ||||||
MIRT446042 | HMCN1 | hemicentin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447968 | MSH6 | mutS homolog 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448634 | ONECUT1 | one cut homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449316 | MRO | maestro | ![]() |
![]() |
2 | 2 | ||||||
MIRT451380 | C19orf43 | telomerase RNA component interacting RNase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451547 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451807 | CDCA3 | cell division cycle associated 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT451916 | ILK | integrin linked kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451938 | TMPRSS5 | transmembrane protease, serine 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452189 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452498 | HMGXB3 | HMG-box containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452548 | ZNF467 | zinc finger protein 467 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453844 | SDK1 | sidekick cell adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454515 | ZFYVE27 | zinc finger FYVE-type containing 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455363 | KDM5C | lysine demethylase 5C | ![]() |
![]() |
2 | 2 | ||||||
MIRT455455 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT455628 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | ![]() |
![]() |
2 | 10 | ||||||
MIRT455639 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT455690 | GLO1 | glyoxalase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT456300 | ASH1L | ASH1 like histone lysine methyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT456784 | MTHFSD | methenyltetrahydrofolate synthetase domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT456819 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | ![]() |
![]() |
2 | 2 | ||||||
MIRT457566 | ZNF34 | zinc finger protein 34 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457604 | IDS | iduronate 2-sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT458236 | NXPH3 | neurexophilin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458313 | TNFAIP8L3 | TNF alpha induced protein 8 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458350 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT458670 | GPR35 | G protein-coupled receptor 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459675 | VPS37C | VPS37C, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT461126 | RAB36 | RAB36, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT461918 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462301 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | ![]() |
![]() |
2 | 2 | ||||||
MIRT463520 | ZBTB7B | zinc finger and BTB domain containing 7B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464378 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464614 | UBE4B | ubiquitination factor E4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464711 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465520 | PRICKLE4 | prickle planar cell polarity protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465974 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT466058 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466548 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466647 | TAGLN2 | transgelin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467357 | SP2 | Sp2 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT468744 | SDC2 | syndecan 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470244 | PRRC2A | proline rich coiled-coil 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT471426 | PDIA6 | protein disulfide isomerase family A member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471732 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472190 | NHP2L1 | small nuclear ribonucleoprotein 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472450 | NAV2 | neuron navigator 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT474563 | KLHDC3 | kelch domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474936 | KCTD15 | potassium channel tetramerization domain containing 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475165 | IP6K1 | inositol hexakisphosphate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475399 | ICMT | isoprenylcysteine carboxyl methyltransferase | ![]() |
![]() |
2 | 4 | ||||||
MIRT475426 | ICK | intestinal cell kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT477090 | FAM168A | family with sequence similarity 168 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT478458 | DAB2 | DAB2, clathrin adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT478953 | COX15 | COX15, cytochrome c oxidase assembly homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT480096 | CALR | calreticulin | ![]() |
![]() |
2 | 2 | ||||||
MIRT481924 | ANKRD33B | ankyrin repeat domain 33B | ![]() |
![]() |
2 | 2 | ||||||
MIRT483217 | APOA1 | apolipoprotein A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT483882 | TGIF1 | TGFB induced factor homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483923 | SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483942 | LENG8 | leukocyte receptor cluster member 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT484209 | SUMO1 | small ubiquitin-like modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484512 | SYT7 | synaptotagmin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484709 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485356 | MYO1C | myosin IC | ![]() |
![]() |
2 | 4 | ||||||
MIRT485615 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT486584 | ZNF619 | zinc finger protein 619 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487013 | C2orf82 | chromosome 2 open reading frame 82 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487621 | C20orf96 | chromosome 20 open reading frame 96 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487801 | GPR20 | G protein-coupled receptor 20 | ![]() |
![]() |
2 | 4 | ||||||
MIRT488134 | GPR107 | G protein-coupled receptor 107 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488773 | FXYD1 | FXYD domain containing ion transport regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488854 | UBTF | upstream binding transcription factor, RNA polymerase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT489783 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490102 | FN3K | fructosamine 3 kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT490389 | LHFPL3 | LHFPL tetraspan subfamily member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490434 | MYL9 | myosin light chain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490451 | GLUD1 | glutamate dehydrogenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490880 | OSBP | oxysterol binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT491037 | ALPK3 | alpha kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491250 | HCN2 | hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491748 | SEMA3F | semaphorin 3F | ![]() |
![]() |
2 | 2 | ||||||
MIRT492235 | SLC48A1 | solute carrier family 48 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492490 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492505 | RANBP10 | RAN binding protein 10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT492773 | PDGFB | platelet derived growth factor subunit B | ![]() |
![]() |
2 | 2 | ||||||
MIRT492922 | NFAT5 | nuclear factor of activated T-cells 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493459 | ITFG3 | family with sequence similarity 234 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT493654 | HDLBP | high density lipoprotein binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT494011 | DUSP9 | dual specificity phosphatase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499412 | PLCG2 | phospholipase C gamma 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT499552 | C15orf43 | telomere repeat binding bouquet formation protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501836 | NCOA2 | nuclear receptor coactivator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501950 | MAT2A | methionine adenosyltransferase 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT504066 | KCTD12 | potassium channel tetramerization domain containing 12 | ![]() |
![]() |
2 | 4 | ||||||
MIRT504509 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | ![]() |
![]() |
2 | 2 | ||||||
MIRT508466 | HOXB6 | homeobox B6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512373 | CPM | carboxypeptidase M | ![]() |
![]() |
2 | 2 | ||||||
MIRT513578 | EVX1 | even-skipped homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517763 | ZNF366 | zinc finger protein 366 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519773 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 8 | ||||||
MIRT523568 | GGCX | gamma-glutamyl carboxylase | ![]() |
![]() |
2 | 4 | ||||||
MIRT532802 | CLDN11 | claudin 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544299 | TSPYL1 | TSPY like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544862 | MYH2 | myosin heavy chain 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT556731 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT564347 | AKR1B10 | aldo-keto reductase family 1 member B10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568924 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569012 | CXorf36 | chromosome X open reading frame 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569256 | FAM129B | family with sequence similarity 129 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT569591 | PRELP | proline and arginine rich end leucine rich repeat protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT569779 | SAMD14 | sterile alpha motif domain containing 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570034 | FAM228A | family with sequence similarity 228 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT573803 | FRMPD4 | FERM and PDZ domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574190 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576153 | Hmox1 | heme oxygenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611311 | CA8 | carbonic anhydrase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT673429 | APAF1 | apoptotic peptidase activating factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674976 | SH3BP2 | SH3 domain binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692712 | MEAF6 | MYST/Esa1 associated factor 6 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|